GO:0048745 smooth muscle tissue development: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048745 (smooth muscle tissue development) describes the biological process by which smooth muscle progresses over time from its formation to the mature structure.
• Smooth muscle tissue development is driven by a conserved transcriptional program and by reciprocal signaling between smooth muscle cells and adjacent epithelia, nerves, and extracellular matrix.
• In vertebrates, smooth muscle cells arise from multiple embryonic origins, including mesoderm, neural crest, and local mesenchymal progenitors, and their specification depends on spatiotemporally controlled signaling.
• Visceral smooth muscle development is a stepwise process of proliferation, elongation, alignment, and functional maturation that continues into late fetal and early postnatal life.
• Contractile maturation requires the coordinated expression of contractile proteins and the assembly of a functional actomyosin apparatus whose regulation is shared with adult smooth muscle contraction mechanisms.
• Dysregulated smooth muscle tissue development contributes to congenital hollow-organ malformations, fibrotic and neoplastic stromal remodeling, and tissue-engineering challenges.
Description
GO:0048745, smooth muscle tissue development, is the biological process whose specific outcome is the progression of smooth muscle over time, from its formation to the mature structure. Smooth muscle is the involuntary contractile tissue of hollow organs, blood vessels, airways, and the gastrointestinal, urinary, and reproductive tracts, and its developmental specification is a central question in organogenesis. The term therefore captures not a single molecular event but a temporally ordered program that begins with progenitor specification and ends with a mature, contractile, innervated tissue. Understanding GO:0048745 matters because smooth muscle is both a structural scaffold and a signaling partner for adjacent epithelia, and defects in its development are linked to malformations and to altered stromal-epithelial interactions in disease. In vertebrates, smooth muscle cells are derived from several embryonic sources, and their development is controlled by conserved signaling pathways and transcription factors that have been characterized across model organisms. In humans, the layered architecture of visceral smooth muscle is established during embryonic and fetal development in a defined temporal and spatial sequence, which provides a framework for interpreting developmental disorders. Because mature smooth muscle function depends on contractile machinery whose regulation is well described at the physiological level, developmental studies of GO:0048745 connect directly to the mechanisms of smooth muscle contraction. Finally, the inability to faithfully reproduce mature smooth muscle in vitro is a recognized bottleneck in regenerative medicine and tissue engineering, making a precise understanding of GO:0048745 clinically relevant.
smooth muscle tissue development At A Glance
| GO ID | GO:0048745 |
|---|---|
| GO term | smooth muscle tissue development |
| Ontology | biological_process |
| Synonym | none listed in QuickGO |
| Definition | The process whose specific outcome is the progression of smooth muscle over time, from its formation to the mature structure. |
| Major function | Specification, differentiation, and maturation of smooth muscle cells into functional contractile tissue |
| Embryonic origins | Multiple origins including mesoderm, neural crest, and local mesenchymal progenitors |
| Key tissue contexts | Vascular, gastrointestinal, airway, urinary, and reproductive smooth muscle |
| Related physiological process | Smooth muscle contraction, which depends on actomyosin regulation |
What Is GO:0048745?
GO:0048745 (smooth muscle tissue development) is defined in QuickGO as the process whose specific outcome is the progression of smooth muscle over time, from its formation to the mature structure. In practical terms, this covers the specification of smooth muscle progenitors, their proliferation and migration, their differentiation into contractile smooth muscle cells, the assembly of tissue-level architecture such as layered sheets and bundles, and the maturation of the tissue into a functional contractile unit. The term is a biological process and is distinct from the molecular functions of individual contractile proteins and from the cellular component organization of the contractile apparatus, although these are mechanistically coupled during development.
Why Is smooth muscle tissue development Important in Cell Biology?
GO:0048745 is important because smooth muscle tissue is essential for the function of nearly every hollow organ system, and its development determines organ architecture, contractile capacity, and epithelial-stromal signaling. Defects in smooth muscle development are associated with malformations of the gastrointestinal and urinary tracts and with abnormal stromal-epithelial interactions in the prostate and other organs. Because smooth muscle acts as a mechanical sculptor of epithelial shape, developmental errors propagate into broader organ patterning defects. In addition, the limited ability to generate mature smooth muscle in vitro constrains tissue engineering and regenerative approaches for hollow-organ repair. Studying GO:0048745 therefore informs developmental biology, disease mechanisms, and translational strategies.
• Smooth muscle tissue development establishes the contractile layers required for peristalsis, vascular tone, and hollow-organ function.
• Multiple embryonic origins and signaling inputs make GO:0048745 a paradigm for studying cell-fate specification in vertebrates.
• Temporal and spatial staging of human intestinal smooth muscle development provides a reference for developmental pathology.
• Smooth muscle-epithelial interactions during development influence normal and neoplastic prostatic growth.
• Mechanical signaling from developing smooth muscle shapes adjacent epithelial tissues.
• Contractile maturation during development shares regulatory logic with adult smooth muscle contraction.
• Insufficient in vitro maturation of smooth muscle is a barrier to tissue engineering of hollow organs.
• Dysregulated smooth muscle development contributes to fibrosis and tumor stroma remodeling.
• Understanding GO:0048745 supports rational design of cell sources for regenerative medicine.
• Conserved developmental programs allow cross-species comparison of smooth muscle formation.
What Happens During smooth muscle tissue development?
Specification of smooth muscle progenitors
In simple terms: The first step is deciding which embryonic cells will become smooth muscle.
Smooth muscle cells in vertebrates arise from multiple embryonic sources, including mesoderm, neural crest, and local mesenchymal progenitors, and their specification depends on spatiotemporally controlled signaling. This step establishes the pool of committed progenitors that will later differentiate and assemble into tissue layers.
Proliferation, migration, and spatial organization
In simple terms: Progenitor cells multiply and move into position to form layered sheets.
After specification, progenitors proliferate and migrate to their target organ sites, where they organize into the layered architecture characteristic of visceral and vascular smooth muscle. In the human intestine, the smooth muscle layers develop in a defined temporal and spatial sequence during embryonic and fetal life.
Differentiation and contractile protein expression
In simple terms: Cells begin making the proteins that let them contract.
Differentiation involves the expression of smooth muscle contractile and cytoskeletal proteins and the assembly of a functional actomyosin apparatus. The regulatory mechanisms that control contraction in mature smooth muscle, including calcium-dependent and calcium-sensitization pathways, are closely related to the machinery that matures during development.
Tissue-level maturation and mechanical function
In simple terms: The tissue becomes a working contractile unit that also shapes nearby tissues.
Maturation produces a functional contractile tissue that can generate tone and phasic contractions, and developing smooth muscle also acts mechanically on adjacent epithelia to sculpt organ shape. This mechanical role means that smooth muscle development is not only a contractile program but also a morphogenetic one.
Reciprocal interactions with epithelia and stroma
In simple terms: Developing smooth muscle and neighboring cells signal back and forth.
Smooth muscle-epithelial interactions are essential in normal and neoplastic prostatic development, illustrating that GO:0048745 is embedded in reciprocal tissue signaling. These interactions influence both smooth muscle maturation and epithelial growth and differentiation.
Key Genes Involved in GO:0048745 smooth muscle tissue development
The genes and proteins below are established contributors to smooth muscle tissue development and its contractile maturation, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYH11 | Smooth muscle myosin heavy chain, core contractile protein | Marker of mature smooth muscle and contractile maturation |
| ACTA2 | Smooth muscle alpha-actin, contractile and cytoskeletal component | Widely used differentiation marker in developmental studies |
| MYOCD | Transcriptional coactivator of the smooth muscle differentiation program | Central regulator of smooth muscle gene expression |
| SRF | Serum response factor, partners with MYOCD to activate contractile genes | Core transcriptional node in smooth muscle specification |
| TAGLN | Smooth muscle protein 22-alpha, actin-binding protein | Marker of differentiated smooth muscle |
| CNN1 | Calponin, actin-binding regulatory protein | Marker of contractile smooth muscle maturation |
| MYL9 | Regulatory myosin light chain | Component of the contractile apparatus |
| MYLK | Myosin light chain kinase | Calcium-dependent regulator of contraction |
| PPP1R14A | CPI-17, inhibitor of myosin light chain phosphatase | Calcium sensitization regulator |
| NOTCH2 | Signaling receptor in vascular and visceral smooth muscle development | Pathway controlling progenitor differentiation |
| PDGFRB | Receptor tyrosine kinase in smooth muscle progenitor recruitment | Signaling node in mural cell and smooth muscle development |
| TGFB1 | Ligand promoting smooth muscle differentiation | Extracellular cue in smooth muscle maturation |
| BMP4 | Ligand influencing smooth muscle and stromal patterning | Developmental signaling input |
| WNT5A | Non-canonical Wnt ligand in mesenchymal development | Regulator of smooth muscle progenitor behavior |
| ELN | Elastin, extracellular matrix component of mature smooth muscle tissue | Matrix maturation marker |
| COL1A1 | Collagen, extracellular matrix of smooth muscle layers | Stromal maturation and fibrosis relevance |
| DES | Desmin, intermediate filament in smooth muscle | Cytoskeletal maturation marker |
How Is smooth muscle tissue development Regulated?
Smooth muscle tissue development is regulated by a combination of transcriptional programs and extracellular signaling. The MYOCD-SRF axis activates contractile and cytoskeletal gene expression during differentiation, while Notch, PDGF, TGF-beta, BMP, and Wnt signals control progenitor specification, proliferation, and maturation in a context-dependent manner. In the prostate, reciprocal epithelial-stromal signaling regulates smooth muscle development and is also implicated in neoplastic remodeling. At the level of contractile function, calcium-dependent activation of myosin light chain kinase and calcium-sensitization pathways involving Rho-associated signaling and CPI-17 regulate the contractile state of differentiated smooth muscle, and these mechanisms are relevant to the functional maturation of the tissue. Mechanical cues from the extracellular matrix and from adjacent epithelia also feed back on smooth muscle organization during development.
smooth muscle tissue development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYOCD | Smooth muscle differentiation defects and stromal remodeling | Knockout and overexpression cell models |
| ACTA2 | Contractile maturation and fibrosis-associated remodeling | Point-mutation and tagged knock-in models |
| MYH11 | Contractile dysfunction and hollow-organ malformation | Knock-in and knockout models |
| PDGFRB | Progenitor recruitment defects in vascular and visceral development | Knockout and point-mutation models |
| TGFB1 | Fibrotic and stromal-epithelial pathology | Overexpression and knockout models |
Congenital hollow-organ malformations
Because GO:0048745 establishes the layered smooth muscle architecture of hollow organs, disruptions in the temporal and spatial sequence of human intestinal smooth muscle development can contribute to congenital malformations of the gastrointestinal and urinary tracts. The staged nature of human intestinal smooth muscle development provides a framework for identifying the developmental windows most vulnerable to such defects.
Prostatic disease and stromal-epithelial pathology
Smooth muscle-epithelial interactions are central to normal and neoplastic prostatic development, and altered smooth muscle development or stromal signaling can promote pathological epithelial growth. This makes GO:0048745 relevant to understanding the stromal contribution to prostate disease.
Fibrosis and tumor stroma
Developmental programs that build smooth muscle tissue are partially reactivated in fibrotic and neoplastic stroma, where altered smooth muscle and matrix production remodel organ architecture. The extracellular matrix components that mature during smooth muscle development, such as collagens and elastin, are also central to fibrotic remodeling.
Regenerative medicine and tissue engineering limitations
The inability to reliably generate mature, functional smooth muscle in vitro limits the engineering of hollow organs and vascular grafts, and this gap is directly tied to incomplete recapitulation of GO:0048745. Adult stem cell sources are being explored to overcome these limitations, but full developmental maturation remains a challenge.
From smooth muscle tissue development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for smooth muscle progenitor specification? | CRISPR knockout in progenitor cell lines or organoid models |
| Does a specific variant alter contractile protein function? | CRISPR point-mutation knock-in in smooth muscle cell lines |
| Can a reporter track smooth muscle differentiation in real time? | Tagged knock-in of a contractile gene such as MYH11 |
| Does forced expression of a transcription factor drive smooth muscle fate? | Overexpression of MYOCD or SRF in mesenchymal cells |
| Does a signaling ligand promote smooth muscle maturation? | Overexpression or knockout of TGFB1, BMP4, or WNT5A |
| Can adult stem cells be directed toward smooth muscle for engineering? | Stem cell differentiation with CRISPR validation of lineage regulators |
How to Study the smooth muscle tissue development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA sequencing | Transcriptional program across developmental stages | Staging human intestinal smooth muscle development |
| Lineage tracing | Embryonic origin and fate of smooth muscle progenitors | Mapping mesoderm, neural crest, and mesenchymal contributions |
| Immunohistochemistry | Protein markers of differentiated smooth muscle | Detecting ACTA2, MYH11, and CNN1 in tissue sections |
| Calcium imaging and contractility assays | Functional contractile maturation | Assessing myosin light chain kinase-dependent contraction |
| Myosin light chain phosphorylation assays | Calcium sensitization state | Evaluating regulatory pathway activity |
| Extracellular matrix analysis | Elastin and collagen deposition | Assessing matrix maturation of smooth muscle layers |
| Epithelial morphogenesis imaging | Mechanical shaping of adjacent epithelia | Studying smooth muscle as a mechanical sculptor |
| Stem cell differentiation assays | Efficiency of smooth muscle lineage induction | Evaluating adult stem cell sources for engineering |
Transcriptional profiling of developing smooth muscle
RNA sequencing of staged embryonic and fetal tissues can resolve the temporal program of smooth muscle gene expression, as illustrated by studies of human intestinal smooth muscle layer development. Comparing developmental stages identifies when contractile and matrix genes are activated.
Lineage tracing and progenitor origin mapping
Genetic lineage tracing in vertebrate models has been used to define the multiple embryonic origins of smooth muscle cells and to map their contributions to different organs. These approaches are essential for assigning progenitors to specific smooth muscle beds.
Contractile function and regulatory pathway assays
Measurements of calcium-dependent contraction, myosin light chain phosphorylation, and calcium sensitization are used to assess functional maturation of smooth muscle, building on established mechanisms of smooth muscle contraction. These assays link developmental gene expression to physiological output.
Tissue architecture and mechanical interaction imaging
Imaging of layered smooth muscle architecture and of smooth muscle-epithelial interfaces reveals how developing smooth muscle sculpts epithelial shape and organizes organ structure. Such imaging is complemented by matrix composition analysis of elastin and collagens.
How CRISPR Can Be Used to Study GO:0048745 smooth muscle tissue development
Knockout
CRISPR knockout of candidate regulators such as MYOCD, SRF, or PDGFRB can test whether a gene is required for smooth muscle progenitor specification and differentiation. Knockout of contractile genes such as MYH11 or ACTA2 can reveal their roles in contractile maturation.
Point Mutation
Point-mutation knock-in can model disease-associated variants in contractile or signaling genes and test their effects on smooth muscle differentiation and function. This approach is useful when complete loss of function is lethal or when a specific amino acid change is suspected to alter regulation.
Knock-in
Tagged knock-in of endogenous smooth muscle genes, such as a fluorescent reporter at the MYH11 locus, enables real-time tracking of differentiation and maturation in living cells. Knock-in of signaling pathway components can also be used to monitor pathway activity during development.
Overexpression
Overexpression of transcription factors or ligands such as MYOCD, TGFB1, or BMP4 can test sufficiency for driving smooth muscle fate or maturation in mesenchymal and stem cell models. Overexpression is particularly useful for probing gain-of-function contributions to stromal remodeling.
How EDITGENE Supports smooth muscle tissue development Research
Researchers studying smooth muscle tissue development-related genes often need to determine whether a candidate gene is causally involved in progenitor specification, differentiation, or contractile maturation, and CRISPR-based cell models provide a controlled way to test these hypotheses.
Contact EDITGENE today to design your custom CRISPR model for smooth muscle tissue development research.
Frequently Asked Questions About smooth muscle tissue development
What is GO:0048745?
GO:0048745 is the Gene Ontology biological process term for smooth muscle tissue development, defined as the process whose specific outcome is the progression of smooth muscle over time, from its formation to the mature structure.
What does smooth muscle tissue development mean?
It means the full developmental program by which smooth muscle progenitors are specified, differentiate, and mature into functional contractile tissue in organs such as the gut, vasculature, and urinary tract.
What genes are involved in smooth muscle tissue development?
Key genes include the transcriptional regulators MYOCD and SRF, contractile genes such as MYH11, ACTA2, CNN1, and TAGLN, and signaling genes including NOTCH2, PDGFRB, TGFB1, BMP4, and WNT5A.
Where do smooth muscle cells come from during development?
In vertebrates, smooth muscle cells arise from multiple embryonic origins, including mesoderm, neural crest, and local mesenchymal progenitors.
How does human intestinal smooth muscle develop?
Human intestinal smooth muscle layers develop in a defined temporal and spatial sequence during embryonic and fetal life.
What is the role of smooth muscle in organ development?
Developing smooth muscle acts as a mechanical sculptor of epithelial shape and participates in reciprocal epithelial-stromal signaling.
How is smooth muscle contraction related to its development?
Contractile maturation during development establishes the actomyosin machinery whose regulation, including calcium-dependent myosin light chain kinase activity and calcium sensitization, controls contraction in mature tissue.
What diseases are linked to defective smooth muscle development?
Defects have been linked to congenital hollow-organ malformations, prostatic stromal-epithelial pathology, and fibrotic or neoplastic stromal remodeling.
Why is smooth muscle tissue engineering difficult?
A major challenge is reproducing mature, functional smooth muscle in vitro, which reflects incomplete recapitulation of the developmental program.
How can CRISPR help study smooth muscle tissue development?
CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of candidate genes in progenitor specification, differentiation, and contractile maturation.
Conclusion
GO:0048745 (smooth muscle tissue development) captures a multi-step developmental program that spans progenitor specification, proliferation, differentiation, tissue-level organization, and functional maturation. The process is controlled by conserved transcriptional and signaling networks and is essential for hollow-organ architecture and function. Because defects in this program are linked to malformations, stromal disease, and tissue-engineering limitations, it remains a high-value target for developmental and translational research. CRISPR-based cell models provide a rigorous way to test causal roles of individual genes within this process.
References
- 1. Baldwin CS et al.. 2024. The challenges and prospects of smooth muscle tissue engineering.. Regen Med 19(3):135-143 PMID: 38440898
- 2. Donadon M et al.. 2021. The origin and mechanisms of smooth muscle cell development in vertebrates.. Development 148(7) PMID: 33789914
- 3. Salemi S et al.. 2022. Adult stem cell sources for skeletal and smooth muscle tissue engineering.. Stem Cell Res Ther 13(1):156 PMID: 35410452
- 4. Liu X et al.. 2023. Temporal and spatial development of intestinal smooth muscle layers of human embryos and fetuses.. J Dev Orig Health Dis 14(1):24-32 PMID: 35924440
- 5. Gabella G. 2002. Development of visceral smooth muscle.. Results Probl Cell Differ 38:1-37 PMID: 12132390
- 6. Jaslove JM et al.. 2018. Smooth muscle: a stiff sculptor of epithelial shapes.. Philos Trans R Soc Lond B Biol Sci 373(1759) PMID: 30249770
- 7. Cunha GR et al.. 1996. Smooth muscle-epithelial interactions in normal and neoplastic prostatic development.. Acta Anat (Basel) 155(1):63-72 PMID: 8811117
- 8. Horowitz A et al.. 1996. Mechanisms of smooth muscle contraction.. Physiol Rev 76(4):967-1003 PMID: 8874491
